Advertisement

Ads Placeholder
Loading...

Lifeward Ltd.

LFWDNASDAQ
Healthcare
Medical - Devices
$6.86
$0.06(0.88%)
U.S. Market opens in 52h 4m

Lifeward Ltd. Fundamental Analysis

Lifeward Ltd. (LFWD) shows moderate financial fundamentals with a PE ratio of -0.51, profit margin of -90.38%, and ROE of -1.46%. The company generates $0.0B in annual revenue with strong year-over-year growth of 85.24%.

Key Strengths

Cash Position21.26%
PEG Ratio-0.01

Areas of Concern

ROE-1.46%
Operating Margin-76.66%
We analyze LFWD's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -185.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-185.6/100

We analyze LFWD's fundamental strength across five key dimensions:

Efficiency Score

Weak

LFWD struggles to generate sufficient returns from assets.

ROA > 10%
-86.96%

Valuation Score

Excellent

LFWD trades at attractive valuation levels.

PE < 25
-0.51
PEG Ratio < 2
-0.01

Growth Score

Moderate

LFWD shows steady but slowing expansion.

Revenue Growth > 5%
85.24%
EPS Growth > 10%
-28.57%

Financial Health Score

Excellent

LFWD maintains a strong and stable balance sheet.

Debt/Equity < 1
0.19
Current Ratio > 1
1.31

Profitability Score

Weak

LFWD struggles to sustain strong margins.

ROE > 15%
-145.55%
Net Margin ≥ 15%
-90.38%
Positive Free Cash Flow
No

Key Financial Metrics

Is LFWD Expensive or Cheap?

P/E Ratio

LFWD trades at -0.51 times earnings. This suggests potential undervaluation.

-0.51

PEG Ratio

When adjusting for growth, LFWD's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Lifeward Ltd. at 1.21 times its book value. This may indicate undervaluation.

1.21

EV/EBITDA

Enterprise value stands at -0.67 times EBITDA. This is generally considered low.

-0.67

How Well Does LFWD Make Money?

Net Profit Margin

For every $100 in sales, Lifeward Ltd. keeps $-90.38 as profit after all expenses.

-90.38%

Operating Margin

Core operations generate -76.66 in profit for every $100 in revenue, before interest and taxes.

-76.66%

ROE

Management delivers $-1.46 in profit for every $100 of shareholder equity.

-1.46%

ROA

Lifeward Ltd. generates $-86.96 in profit for every $100 in assets, demonstrating efficient asset deployment.

-86.96%

Following the Money - Real Cash Generation

Operating Cash Flow

Lifeward Ltd. generates limited operating cash flow of $-17.29M, signaling weaker underlying cash strength.

$-17.29M

Free Cash Flow

Lifeward Ltd. generates weak or negative free cash flow of $-17.30M, restricting financial flexibility.

$-17.30M

FCF Per Share

Each share generates $-11.32 in free cash annually.

$-11.32

FCF Yield

LFWD converts -1.61% of its market value into free cash.

-1.61%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.51

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.21

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.48

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.19

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.31

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.46

vs 25 benchmark

ROA

Return on assets percentage

-0.87

vs 25 benchmark

ROCE

Return on capital employed

-1.56

vs 25 benchmark

How LFWD Stacks Against Its Sector Peers

MetricLFWD ValueSector AveragePerformance
P/E Ratio-0.5128.45 Better (Cheaper)
ROE-145.55%763.00% Weak
Net Margin-90.38%-45265.00% (disorted) Weak
Debt/Equity0.190.34 Strong (Low Leverage)
Current Ratio1.312795.60 Neutral
ROA-86.96%-16588.00% (disorted) Weak

LFWD outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Lifeward Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-50.11%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

82.37%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

86.11%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ